A CRISPR-Cas9 system protecting E. coli against acquisition of antibiotic resistance genes
Abstract Antimicrobial resistance (AMR) is an increasing problem worldwide, and new treatment options for bacterial infections are direly needed. Engineered probiotics show strong potential in treating or preventing bacterial infections. However, one concern with the use of live bacteria is the risk...
Saved in:
Main Authors: | Danna Lee, Petra Muir, Sara Lundberg, August Lundholm, Linus Sandegren, Sanna Koskiniemi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-85334-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9
by: Akram Hosen, et al.
Published: (2025-01-01) -
CRISPR/Cas9-editing of PRNP in Alpine goats
by: Aurélie Allais-Bonnet, et al.
Published: (2025-01-01) -
Assessing spacer acquisition rates in E. coli type I-E CRISPR arrays
by: Luke J. Peach, et al.
Published: (2025-01-01) -
Exploiting CRISPR/Cas system in controlling antibiotic resistance of bacteria
by: Pourya Gholizadeh, et al.
Published: (2024-07-01) -
CRISPR/Cas9, a universal tool for genomic engineering
by: A. V. Smirnov, et al.
Published: (2016-09-01)